on June 13, 2013 |
Permalink
Topics: Service Lines, Clinical Research, Oncology, Lab
Nicholas Bartz, Oncology Roundtable
In a landmark decision, sure to have enormous ramifications across the health care and biotechnology industries, the Supreme Court ruled today that naturally occurring genes cannot be patented—but synthetic genes can.
As a result, Myriad Genetics, who has patent claims on both the BRCA1 and BRCA2 genes, may lose its status as sole provider of BRCA genetic testing.
Continue reading:
Supreme Court rules against patents on human DNA
on May 28, 2013 |
Permalink
Topics: Clinical Research, Service Lines, Oncology
Deirdre Fuller, Oncology Roundtable
Are you struggling with your cancer clinical trial accrual rates? Learn how you can improve your numbers.
There are few evidence-based practices to help cancer programs improve clinical trial accruals. The Education Network to Advance Cancer Clinical Trials (ENACCT) has developed a learning program using quality improvement methodology, expert faculty, dedicated coaches, and social networking to foster collaboration between cancer centers.
Continue reading:
Apply now: ENACCT’s clinical trial collaborative
on May 15, 2013 |
Permalink
Topics: Oncology, Service Lines, Quality, Performance Improvement, Patient-Focused Care, Methodologies
Deirdre Fuller, Oncology Roundtable
According to preliminary data from our Patient Experience Quick Poll, over half of all cancer programs provide cancer patients with a dedicated phone line to call if they have urgent symptom needs and almost a quarter have hired clinicians just to treat patients with urgent symptom needs.
How are you improving your patients’ care experience?
Continue reading:
How are you improving your patients’ experience?
